ENPeople with chronic viral hepatitis and their families look for reviews of hepatitis treatment in Germany when considering treatment there, to learn how it went for patients who went before them. In plain words, hepatitis is inflammation of the liver, most often caused by the viruses B, C and D, less often by the body’s own immune system (autoimmune hepatitis).
Reviews from AlenMed patients appear here only with their authors’ consent. The page also explains why experience with different kinds of hepatitis cannot be compared and what to check besides reviews, names hepatology departments (hepatology is the field of medicine dealing with the liver) and describes how an assessment is arranged. Liver treatment in Germany in general is covered on a separate page.
Patient reviews of hepatitis treatment in Germany
There are no reviews from AlenMed patients about hepatitis treatment here yet: each will appear only with the author’s written consent and to the extent they allow, and none will be invented. The rules: only genuine reviews from AlenMed patients about hepatitis treatment or assessment, only with the authors’ consent, and only spelling and punctuation corrected. Before the reviews comes a disclaimer: each describes one person’s experience; it is not a promise of the same result and not a reason to change your treatment.
How to read other people’s accounts is covered in the general section of reviews of treatment in Germany.
Why experience with hepatitis B, C and D cannot be compared
Because these are different diseases with different treatment and outcomes. In hepatitis C, modern antiviral tablets clear the virus in most patients, as the WHO fact sheet on hepatitis C also states. These are direct-acting antivirals: they act on the virus itself and stop it from multiplying. That is why hepatitis C stories more often have an ending.
In hepatitis B, treatment usually suppresses the virus and protects the liver but often lasts for years, so a review about «fast results» is the exception here. Hepatitis D occurs only together with B and is harder to treat. The current guideline of the German Society of Gastroenterology (DGVS) names two options with proven effect: bulevirtide, a medicine approved in Europe that stops the virus from entering liver cells, and pegylated interferon alfa; which one suits a given patient is decided at an experienced hepatology centre.
But what most distinguishes one story from another is the state of the liver: the degree of fibrosis and whether there is cirrhosis. Fibrosis is scarring: dense scar tissue grows where liver cells have died, and cirrhosis is advanced fibrosis in which the scars reshape the whole organ. What can be done at that stage is explained on the page on liver cirrhosis treatment.
How to read reviews of hepatitis treatment
Read a review as one person’s case and look for four things. First, which hepatitis the author had and at what stage. Second, which tests were done: viral load, which shows how much virus is in the blood, and elastography, which measures liver stiffness with ultrasound and is used to assess fibrosis. Third, whether the doctor clearly explained the treatment plan and how it would be monitored. Fourth, how contact with the doctor was organised after returning home.
Warning signs are promises to «cleanse the liver» or to cure hepatitis B for good, «unique» methods that are not in medical guidelines, and advice to stop prescribed medicines. Antiviral treatment must not be stopped on one’s own: in hepatitis B the disease may flare up after the tablets are stopped, and in hepatitis C the medicine has the best chance of clearing the virus when the full course is completed. Only the doctor in charge of the treatment can stop or change it.
Hepatology departments and doctors
Below are departments that treat liver disease and the doctors who head them. Prof. Dr. med. Hartmut Schmidt is director of the Department of Gastroenterology, Hepatology and Transplant Medicine at University Hospital Essen, with hepatology and transplant medicine among his fields. Univ.-Prof. Dr. Christoph Neumann-Haefelin is director of the Department of Gastroenterology and Hepatology at University Hospital Cologne.
Prof. Dr. med. Axel Dignass is chief physician of Medical Clinic I (gastroenterology, hepatology, oncology, infectious diseases, pulmonology) at Agaplesion Markus Hospital in Frankfurt. Prof. Dr. med. Guntram Lock is chief physician of internal medicine and gastroenterology at Albertinen Hospital in Hamburg, with hepatology and ultrasound among his fields.
Frequently asked questions
Can reviews tell me whether my hepatitis will be cured in Germany?
No: a review tells you how treatment went for someone else, while your outcome depends on the type of virus, the degree of fibrosis, whether there is cirrhosis, earlier treatment and other illnesses. A realistic assessment comes from a hepatologist who has seen your blood tests, ultrasound or elastography results and list of medicines.
Can you trust a review in which hepatitis B was cured with one course?
Only with caution. In hepatitis B, treatment usually suppresses the virus and protects the liver but often lasts for years, so a story of a quick and final cure is the exception. Check which tests confirm the result and who monitors them after the return home. A promise to cure hepatitis B for good is a warning sign, not experience to rely on.
How can you tell a genuine hepatitis treatment review from an advertisement?
By the details: a genuine review shows which hepatitis the author had, which tests were done, who explained the plan and how follow-up worked after returning home. Advertising gives itself away through identical phrases across reviews, promises to «cleanse the liver» and advice to stop prescribed medicines. If a text steers you to one clinic and leaves no questions open, it is more likely an advert than a patient’s experience.
How AlenMed arranges hepatitis treatment in Germany
AlenMed starts with your documents, before any trip. Recent test results are translated (viral markers, viral load, liver function tests), together with ultrasound or elastography results and the list of medicines you take. From them, the hospital’s doctor says in advance which tests will need repeating.
Next come the choice of department, the hospital’s written estimate, the visa invitation, an interpreter at the appointment and translation of the report and treatment plan. A monitoring plan at home is agreed in advance too: who will follow your blood tests after you return. AlenMed’s office is in Munich.
This material is for information only and is not an offer. The treatment plan is decided by a doctor at an in-person consultation.